SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-00-008528
Filing Date
2000-02-25
Accepted
2000-02-25 00:00:00
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G SC 13G 15634
2 EXHIBIT 99(A) EX-99.A 1807
  Complete submission text file 0000912057-00-008528.txt   19737
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121 (858) 860-25
EPIMMUNE INC (Subject) CIK: 0000822206 (see all company filings)

IRS No.: 330245076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46179 | Film No.: 554002
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice